Search the Roll Call archive by keyword, date, Congress, section, or tags.
↵↵The Senate on Wednesday blocked further consideration of a similar war powers resolution, rejecting a motion to discharge the measure from the Senate Foreign Relations Committee on a 47-53 vote.
The House narrowly passed the measure last week along party lines, and the final tally in the Senate was 49-47.
On a 47-0 vote it approved another bill that would commission a report on China's AI capabilities.
The chamber overwhelmingly rejected the Sinema-Tester measure, 10-87, but it gave wavering Democrats cover to reject the Lee amendment, which went down on a 47-50 vote.
Toomey pushed to amend the bill to keep the spending in the discretionary category, but his amendment was defeated in a 47-48 vote.
Polling in July by Co/efficient suggested the vote could be close, with 47 percent of likely primary voters in favor, 43 percent against and 10 percent still undecided.
So far, the political spending resolution has received between 30 percent and 47 percent of votes cast by shareholders in support at Abbvie, AT&T, Charter, Home Depot and Cigna.
Mike Lee, R-Utah, which would have denied funding to enforce any federal vaccine mandates, was shot down on a vote of 46-47.
Fitch rates the credit of 47 states as AA or better, meaning investments are “not significantly vulnerable to foreseeable events,” which includes economic downturns.
Enzi raised a point of order against the amendment, and the chamber voted 47-51 against waiving the point of order, effectively rejecting the amendment.
Efforts to test Zika vaccines at NIH could stall when the agency exhausts the $47 million it received, which NIH projects will occur at the end of August.